The Delaware Court of Chancery has blocked the directors of the biotechnology firm Sorrento Therapeutics Inc. from invoking business judgment protections to guard against derivative claims that they used two schemes to siphon value away from the company and into their own pockets.

Instead, Vice Chancellor Tamika Montgomery-Reeves said it was up to defendants to prove that the actions were fair to the company and its stockholders.